Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.00
0.00 (0.00%)
Jul 31, 2026, 2:30 PM HKT
Market Cap2.78B -42.7%
Revenue (ttm)n/a
Net Income-167.32M
EPS-0.84
Shares Out 198.91M
PE Ration/a
Forward PE24.12
Dividendn/a
Ex-Dividend Daten/a
Volume200
Open14.00
Previous Close14.00
Day's Range14.00 - 14.00
52-Week Range12.00 - 28.00
Beta-0.65
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About HKG:2480

Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, develops human vaccines and therapeutic biologics to prevent and control infectious diseases, and to treat cancer and autoimmune diseases in Mainland China. The company is developing LZ901, a recombinant herpes zoster vaccine for which a biologics license application (BLA) has been submitted; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection that has completed a Phase 1 clinical trial for the treatment of autoimmune diseases, such as rheumatoid ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 193
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2480
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements